HZX-57612-92965
4 vaccinations
6 coded responses
29 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 100 / NY
- Registered
- 2021-01-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-09
Registered in v-safe
-
2021-01-09
Dose 1 — Pfizer-BioNTech
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
-
2021-01-16
Survey response — day 7, dose 1MedDRA: Flushing — Feeling: Fair · FeverFree text: FlushedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-23
-
2021-01-30
Dose 2 — Pfizer-BioNTech
- 2021-01-30
- 2021-02-01
-
2021-02-02
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Muscle or body aches, Fatigue or tirednessFree text: Lymphadenopathy- supraclavicular and posterior chain on side of shorMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-03
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Lymphadenopathy - supraclavicular and posterior chain on side of injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-04
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Lymphadenopathy- improvingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-05
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: LymphadenopathyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-06
- 2021-02-13
- 2021-02-22
- 2021-02-27
- 2021-03-06
- 2021-03-13
- 2021-05-01
- 2021-07-31
-
2021-12-22
Dose 3 — Moderna
- 2022-01-30
-
2022-10-26
Dose 4 — Pfizer-BioNTech
- 2022-11-23
- 2022-12-02
- 2022-12-07
-
2023-01-27
Survey response — 3 months, dose 4MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-27
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-01-30
Call successfulNot applicable - Accidental Reporting
- 2023-04-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-09 | Pfizer-BioNTech | |
| 2 | 2021-01-30 | Pfizer-BioNTech | |
| 3 | 2021-12-22 | Moderna | No |
| 4 | 2022-10-26 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 2 — day 7, dose 1
Systemic reaction (other): Flushed
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Lymphadenopathy- supraclavicular and posterior chain on side of shor
Systemic reaction (other): Lymphadenopathy - supraclavicular and posterior chain on side of injection
Systemic reaction (other): Lymphadenopathy- improving
Systemic reaction (other): Lymphadenopathy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SRO | Flushing | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release